Table 2 3q26 Gains and 3q26/cen7 ratios
No. of cases*3q26 Gain (%)Median 3q26/cen7 (range)
VIN, usual type2412 (50)1.6 (1.2–2.4)
VIN, differentiated type55 (100)1.8 (1.3–2.8)
SCC
    Basaloid21 (50)1.8
    Keratinising1917 (89)1.7 (1.2–2.9)
    Non keratinising63 (50)1.9 (1.4–2.0)
    Warty111.9
  • *Number of cases that we were able to evaluate.

  • SCC, squamous cell carcinoma; VIN, vulvar intraepithelial neoplasia.